Leslie Meltzer
Chief Tech/Sci/R&D Officer at ORCHARD THERAPEUTICS PLC
Leslie Meltzer active positions
Companies | Position | Start | End |
---|---|---|---|
ORCHARD THERAPEUTICS PLC | Chief Tech/Sci/R&D Officer | 2018-05-31 | - |
Career history of Leslie Meltzer
Former positions of Leslie Meltzer
Companies | Position | Start | End |
---|---|---|---|
KERYX BIOPHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 2016-07-31 | 2018-05-31 |
Training of Leslie Meltzer
Stanford University School of Medicine | Doctorate Degree |
Statistics
International
United States | 3 |
United Kingdom | 2 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Orchard Therapeutics Plc
Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Leslie Meltzer
- Experience